Carlsbad, CA – September , 2020
Biotech Startups: How to Succeed in a COVID-19 World, the new e-book from Xconomy and EBD Group, offers advice to startups from biotech experts, entrepreneurs, and investors on how to navigate the obstacles to success when face-to-face meetings may not be possible.
“Even when companies have amazing science or technology and solid IP, it’s still people that drive the company. Having the wrong person on board might not drive the company at all, or drive it in the wrong direction,” – Dan Fero, Managing Director, OMX Ventures and contributor to Biotech Startups: How to Succeed in a COVID-19 World.
Taking a biotech company from concept, through clinical trials, and ultimately to market requires a perfect storm of good science, a sound investment, the right management, and often a bit of luck, especially during these difficult times. Inside Biotech Startups: How to Succeed in a COVID-19 World you’ll discover insights into how a startup can build a leadership team, network, find and meet partners, and perfect a company pitch while also running a startup virtually.
BioPharm America™ Digital, September 21–24, 2020, is where those who have read the e-book can use the insights they have learned toward growing their businesses by connecting with best-fit partners and networking. Several panels at the digital event are also specifically designed to offer startup entrepreneurs the tools they need to reach their next level of success.
Special Sessions for Startups:
When BioPharm America Digital kicks off next week, it will provide numerous opportunities for those in pharmaceuticals and biotechnology to connect with potential partners and investors through one-to-one meetings while gaining expert advice from industry leaders.
This fully digital event features partneringOne, the partnering platform that allows you to identify prospective partners and manage all your meeting requests in one place. With events going digital, partneringONE is more important than ever to help facilitate your networking.
Additional links and information:
About EBD Group
EBD Group’s overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, China Showcase, Digital Medicine & Medtech Showcase, ChinaBio® Partnering Forum, Rare Disease Innovation and Partnering Summit, and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.
EBD Group is an Informa company. For more information please visit www.ebdgroup.com.
(720) 236 7100